Literature DB >> 23002205

Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma.

Xiaolin Wan1, Choh Yeung, Su Young Kim, Joseph G Dolan, Vu N Ngo, Sandra Burkett, Javed Khan, Louis M Staudt, Lee J Helman.   

Abstract

We identified Bub1b as an essential element for the growth and survival of rhabdomyosarcoma (RMS) cells using a bar-coded, tetracycline-inducible short hairpin RNA (shRNA) library screen. Knockdown of Bub1b resulted in suppression of tumor growth in vivo, including the regression of established tumors. The mechanism by which this occurs is via postmitotic endoreduplication checkpoint and mitotic catastrophe. Furthermore, using a chromatin immunoprecipitation assay, we found that Bub1b is a direct transcriptional target of Forkhead Box M1 (FoxM1). Suppression of FoxM1 either by shRNA or the inhibitor siomycin A resulted in reduction of Bub1b expression and inhibition of cell growth and survival. These results show the important role of the Bub1b/FoxM1 pathway in RMS and provide potential therapeutic targets. ©2012 AACR.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23002205      PMCID： PMC3500453          DOI： 10.1158/0008-5472.CAN-12-1991

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  44 in total

1.  Unified nomenclature for the winged helix/forkhead transcription factors.

Authors:  K H Kaestner; W Knochel; D E Martinez
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 2.  Chromosome segregation and cancer: cutting through the mystery.

Authors:  P V Jallepalli; C Lengauer
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

Review 3.  Endoreplication cell cycles: more for less.

Authors:  B A Edgar; T L Orr-Weaver
Journal:  Cell       Date:  2001-05-04       Impact factor: 41.582

Review 4.  From polyploidy to aneuploidy, genome instability and cancer.

Authors:  Zuzana Storchova; David Pellman
Journal:  Nat Rev Mol Cell Biol       Date:  2004-01       Impact factor: 94.444

5.  BUBR1 deficiency results in abnormal megakaryopoiesis.

Authors:  Qi Wang; Tongyi Liu; Yuqiang Fang; Suqing Xie; Xuan Huang; Radma Mahmood; Gita Ramaswamy; Kathleen M Sakamoto; Zbigniew Darzynkiewicz; Ming Xu; Wei Dai
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

6.  Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells.

Authors:  Xiaolin Wan; Lee J Helman
Journal:  Oncogene       Date:  2003-11-06       Impact factor: 9.867

7.  Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency.

Authors:  Wei Dai; Qi Wang; Tongyi Liu; Malisetty Swamy; Yuqiang Fang; Suqing Xie; Radma Mahmood; Yang-Ming Yang; Ming Xu; Chinthalapally V Rao
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

Review 8.  The spindle checkpoint, aneuploidy, and cancer.

Authors:  Rajnish Bharadwaj; Hongtao Yu
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

Review 9.  Losing balance: the origin and impact of aneuploidy in cancer.

Authors:  Andrew J Holland; Don W Cleveland
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

10.  Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway.

Authors:  Xiaolin Wan; Lee J Helman
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715
View more
  25 in total

1.  Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma.

Authors:  Jou-Ho Shih; Hsin-Yi Chen; Shin-Chih Lin; Yi-Chen Yeh; Roger Shen; Yaw-Dong Lang; Dung-Chi Wu; Chien-Yu Chen; Ruey-Hwa Chen; Teh-Ying Chou; Yuh-Shan Jou
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

2.  Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.

Authors:  Yuanyuan Wang; Zihao Zhou; Liang Chen; Yuzheng Li; Zengyuan Zhou; Xia Chu
Journal:  Mol Cell Biochem       Date:  2020-11-01       Impact factor: 3.396

3.  Hyper-active RAS/MAPK introduces cancer-specific mitotic vulnerabilities.

Authors:  Jacob A Herman; Romario R Romain; Pia Hoellerbauer; Hazheen K Shirnekhi; David C King; Keith F DeLuca; Erin Osborne Nishimura; Patrick J Paddison; Jennifer G DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

4.  Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis.

Authors:  Shilpa Kuttikrishnan; Tariq Masoodi; Gulab Sher; Ajaz A Bhat; Kalyani Patil; Tamam El-Elimat; Nicholas H Oberlies; Cedric J Pearce; Mohmmad Haris; Aamir Ahmad; Feras Q Alali; Shahab Uddin
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

5.  FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.

Authors:  Masaaki Kuda; Kenichi Kohashi; Yuichi Yamada; Akira Maekawa; Yoshiaki Kinoshita; Tetsuya Nakatsura; Yukihide Iwamoto; Tomoaki Taguchi; Yoshinao Oda
Journal:  Tumour Biol       Date:  2015-11-09

6.  IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.

Authors:  Xiaolin Wan; Choh Yeung; Christine Heske; Arnulfo Mendoza; Lee J Helman
Journal:  Neoplasia       Date:  2015-04       Impact factor: 5.715

Review 7.  The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.

Authors:  Santiago Rello-Varona; David Herrero-Martín; Laura Lagares-Tena; Roser López-Alemany; Núria Mulet-Margalef; Juan Huertas-Martínez; Silvia Garcia-Monclús; Xavier García Del Muro; Cristina Muñoz-Pinedo; Oscar Martínez Tirado
Journal:  Front Oncol       Date:  2015-04-07       Impact factor: 6.244

8.  Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.

Authors:  Akira Maekawa; Kenichi Kohashi; Masaaki Kuda; Kunio Iura; Takeaki Ishii; Makoto Endo; Tetsuya Nakatsura; Yukihide Iwamoto; Yoshinao Oda
Journal:  BMC Cancer       Date:  2016-07-20       Impact factor: 4.430

9.  Identification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors.

Authors:  Gavin D Grant; Lionel Brooks; Xiaoyang Zhang; J Matthew Mahoney; Viktor Martyanov; Tammara A Wood; Gavin Sherlock; Chao Cheng; Michael L Whitfield
Journal:  Mol Biol Cell       Date:  2013-10-09       Impact factor: 4.138

10.  Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.

Authors:  Akira Maekawa; Kenichi Kohashi; Nokitaka Setsu; Masaaki Kuda; Kunio Iura; Takeaki Ishii; Tomoya Matsunobu; Tetsuya Nakatsura; Yukihide Iwamoto; Yoshinao Oda
Journal:  Cancer Sci       Date:  2016-01-12       Impact factor: 6.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.